Phospholipids and Sphingolipids in Osteoarthritis

Area of Science:

• Biochemistry
• Molecular Biology
• Rheumatology

Background:

• Osteoarthritis (OA) is a major cause of disability.
• Lipid metabolism plays a crucial role in OA pathogenesis.
• Phospholipids (PLs) and sphingolipids (SLs) are key lipid classes involved.

Purpose of the Study:

• To review alterations in PLs and SLs in OA.
• To discuss their roles in joint lubrication, inflammation, and cartilage degradation.
• To explore their potential as diagnostic markers and therapeutic targets for OA.

Main Methods:

• Narrative review of existing literature.
• Analysis of lipid levels in synovial fluid, plasma, serum, and articular tissues.
• Examination of signaling pathways and genetic regulators involved in OA lipid metabolism.

Main Results:

• Elevated levels of specific PLs and SLs are observed in OA patients, correlating with disease severity.
• Individual lipids like LPC 16:0, LPA, C1P, and S1P contribute to OA pathology.
• Cross-species studies in dogs and mice reveal similar lipidomic changes, supporting their use as OA models.

Conclusions:

• PLs and SLs are implicated as potential biomarkers for OA diagnosis and progression monitoring.
• Targeting PL and SL pathways presents a promising therapeutic strategy for OA.
• Further research is needed to translate these lipid-based findings into clinical practice.